[HTML] frontiersin.org

[HTML][HTML] Targeting myeloid-derived suppressor cell, a promising strategy to overcome resistance to immune checkpoint inhibitors

A Hou, K Hou, Q Huang, Y Lei, W Chen - Frontiers in immunology, 2020 - frontiersin.org
Immune checkpoint inhibitors (ICIs) are starting to transform the treatment for patients with
advanced cancer. The extensive application of these antibodies for various cancer obtains …
被引用次数：100 相关文章
[HTML] nih.gov

[HTML][HTML] Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors

A Hou, K Hou, Q Huang, Y Lei, W Chen - Frontiers in Immunology, 2020 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) are starting to transform the treatment for patients with
advanced cancer. The extensive application of these antibodies for various cancer obtains …

Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors.

A Hou, K Hou, Q Huang, Y Lei, W Chen - Frontiers in Immunology, 2020 - europepmc.org
Immune checkpoint inhibitors (ICIs) are starting to transform the treatment for patients with
advanced cancer. The extensive application of these antibodies for various cancer obtains …

[引用][C] Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors

A Hou, K Hou, Q Huang, Y Lei, W Chen - Frontiers in Immunology, 2020 - cir.nii.ac.jp
Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to
Immune Checkpoint Inhibitors | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁 …

Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors

A Hou, K Hou, Q Huang, Y Lei… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) are starting to transform the treatment for patients with
advanced cancer. The extensive application of these antibodies for various cancer obtains …